Universal Health Services financials
$175.73−0.99%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B |
| Gross profit | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $1.99B | $1.68B | $1.18B | $1.14B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B |
| Net income | $1.49B | $1.14B | $717.8M | $675.6M | $991.6M | $941.0M | $812.8M | $778.6M | $752.3M | $702.4M |
| Net margin | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.1% | 7.1% | 7.2% | 7.2% | 7.2% |
| Diluted EPS | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 |
| EBITDA | $2.61B | $2.27B | $1.74B | $1.72B | $1.90B | $1.87B | $1.71B | $1.63B | $1.73B | $1.70B |
| Operating cash flow | $1.86B | $2.07B | $1.27B | $996.0M | $883.7M | $2.36B | $1.44B | $1.27B | $1.25B | $1.33B |
| Free cash flow | $824.5M | $1.12B | $524.7M | $262.0M | $28.0M | $1.63B | $804.4M | $609.8M | $690.1M | $792.4M |
| Diluted shares | 64.5M | 67.9M | 70.1M | 73.8M | 83.7M | 85.6M | 89.0M | 93.8M | 96.3M | 98.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $137.8M | $126.0M | $119.4M | $102.8M | $115.3M | $1.22B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $4.75B | $4.53B | $4.93B | $4.82B | $4.20B | $3.87B |
| Total assets | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B |
| Total liabilities | $8.12B | $7.71B | $7.77B | $7.52B | $6.90B | $7.07B |
| Shareholders' equity | $7.34B | $6.75B | $6.20B | $5.97B | $6.19B | $6.40B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology